Edgen Stock·Sep 12 2025, 00:19戻る
戻る
Oral GLP-1 Race Intensifies as Novo Nordisk Awaits Key FDA Decision
Edgen Stock·Sep 12 2025, 00:19
[1] 1 Reason Every Investor Should Know About Novo Nordisk (NVO) | The Motley Fool (https://www.fool.com/investing/2025/09/08/1-r ...)[2] Novo Nordisk's Oral Weight Loss Pill: A Game-Changer in the $150B Obesity Market (https://vertexaisearch.cloud.google.com/groun ...)[3] Lilly shares fall as obesity pill misses expectations in key trial - BioPharma Dive (https://vertexaisearch.cloud.google.com/groun ...)